COA Responds to CMS Physician Fee Schedule
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
CMS’ proposed 2.8% physician pay decrease for CY2025 earns quick condemnation from docs
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Another Medicare pay cut looms for physicians
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
FTC plans to sue PBMs over the high cost of insulin and other medicines
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
PBM report spurs calls for congressional action
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
FTC Finds PBMs Drive Up Drug Costs, Squeeze Out Competitors
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
FTC says prescription middlemen are squeezing Main Street pharmacies
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
How Drug Middlemen Keep Beating the System
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
There’s a glaring shortage of injectable cancer drugs in market circulation, all because manufacturers are unable to make money off of them, experts told a U.S. House subcommittee last week.
